Peralta-Garcia, A.; Torrens-Fontanals, M.; Stepniewski, T.M.; Grau-Expósito, J.; Perea, D.; Ayinampudi, V.; Waldhoer, M.; Zimmermann, M.; Buzón, M.J.; Genescà, M.;
et al. Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. Int. J. Mol. Sci. 2021, 22, 13592.
https://doi.org/10.3390/ijms222413592
AMA Style
Peralta-Garcia A, Torrens-Fontanals M, Stepniewski TM, Grau-Expósito J, Perea D, Ayinampudi V, Waldhoer M, Zimmermann M, Buzón MJ, Genescà M,
et al. Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. International Journal of Molecular Sciences. 2021; 22(24):13592.
https://doi.org/10.3390/ijms222413592
Chicago/Turabian Style
Peralta-Garcia, Alejandro, Mariona Torrens-Fontanals, Tomasz Maciej Stepniewski, Judith Grau-Expósito, David Perea, Vikram Ayinampudi, Maria Waldhoer, Mirjam Zimmermann, María J. Buzón, Meritxell Genescà,
and et al. 2021. "Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells" International Journal of Molecular Sciences 22, no. 24: 13592.
https://doi.org/10.3390/ijms222413592
APA Style
Peralta-Garcia, A., Torrens-Fontanals, M., Stepniewski, T. M., Grau-Expósito, J., Perea, D., Ayinampudi, V., Waldhoer, M., Zimmermann, M., Buzón, M. J., Genescà, M., & Selent, J.
(2021). Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. International Journal of Molecular Sciences, 22(24), 13592.
https://doi.org/10.3390/ijms222413592